-transparent.png){kind=logo}
Functionalized 2-alkyl derivatives of inosinic acid have been synthesized to serve as reversible as well as irreversible inhibitors of the human type II enzyme inosine monophosphate dehydrogenase. These compounds were designed to react with Cys-331 of the enzyme to form covalent bonds so as to interfere with the normal enzyme mechanism which involves attack of Cys-331 at C-2 of the substrate. Mass spectrometric analysis of the reaction products after enzymatic degradation confirmed the appropriateness of the inhibitor design.
Related Publications
H Z Zhang, and
K Rao, and
S F Carr, and
E Papp, and
K Straub, and
J C Wu, and
J Fried
October 2002,
Bioorganic & medicinal chemistry letters,
H Z Zhang, and
K Rao, and
S F Carr, and
E Papp, and
K Straub, and
J C Wu, and
J Fried
August 2002,
Bioorganic & medicinal chemistry letters,
H Z Zhang, and
K Rao, and
S F Carr, and
E Papp, and
K Straub, and
J C Wu, and
J Fried
August 2009,
Journal of medicinal chemistry,
H Z Zhang, and
K Rao, and
S F Carr, and
E Papp, and
K Straub, and
J C Wu, and
J Fried
July 1995,
Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme,
H Z Zhang, and
K Rao, and
S F Carr, and
E Papp, and
K Straub, and
J C Wu, and
J Fried
October 2002,
Bioorganic & medicinal chemistry letters,
H Z Zhang, and
K Rao, and
S F Carr, and
E Papp, and
K Straub, and
J C Wu, and
J Fried
January 2015,
Journal of enzyme inhibition and medicinal chemistry,
H Z Zhang, and
K Rao, and
S F Carr, and
E Papp, and
K Straub, and
J C Wu, and
J Fried
January 2009,
Advances in enzymology and related areas of molecular biology,
H Z Zhang, and
K Rao, and
S F Carr, and
E Papp, and
K Straub, and
J C Wu, and
J Fried
February 2013,
Bioorganic & medicinal chemistry letters,
H Z Zhang, and
K Rao, and
S F Carr, and
E Papp, and
K Straub, and
J C Wu, and
J Fried
January 2005,
Nucleosides, nucleotides & nucleic acids,
H Z Zhang, and
K Rao, and
S F Carr, and
E Papp, and
K Straub, and
J C Wu, and
J Fried
September 2006,
Current opinion in drug discovery & development,
